Nanoparticle-induced platelet aggregation and vascular thrombosis

British Journal of Pharmacology

Volumn 146, Issue 6, 2005, Pages 882-893

  Radomski, Anna ^a   Jurasz, Paul ^a   Alonso Escolano, David ^a   Drews, Magdalena ^b   Morandi, Maria ^c   Malinski, Tadeusz ^b   Radomski, Marek W ^a,d,e  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b OHIO UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^d MEDICAL UNIVERSITY OF SILESIA   (Poland)

^e NONE   (United States)

Author keywords

Nanoparticles; Platelet aggregation; Vascular thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; CARBON; FERRIC CHLORIDE; FIBRINOGEN RECEPTOR; FULLERENE DERIVATIVE; MATRIX METALLOPROTEINASE; NANOPARTICLE; NANOTUBE; PROSTACYCLIN; PROTEIN KINASE C; S NITROSOGLUTATHIONE; THROMBOXANE;

ANIMAL CELL; ARTICLE; CAROTID ARTERY; COMBUSTION; CONTROLLED STUDY; FLOW CYTOMETRY; GENETIC ENGINEERING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MICROPARTICLE ENZYME IMMUNOASSAY; MOLECULAR INTERACTION; NONHUMAN; PARTICLE SIZE; PARTICULATE MATTER; PRIORITY JOURNAL; RAT; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOSIS; TRANSMISSION ELECTRON MICROSCOPY; ULTRASOUND; UPREGULATION; ZYMOGRAPHY;

EID: 27744508593     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706386     Document Type: Article

References (53)

1. ALONSO-ESCOLANO, D., STRONGIN, A.Y., CHUNG, A.W., DERYUGINA, E.I. & RADOMSKI, M.W. (2004). Membrane type-1 matrix metalloproteinase stimulates tumour cell-induced platelet aggregation: role of receptor glycoproteins. Br. J. Pharmacol., 141, 241-252.
2. AWTRY, E.H. & LOSCALZO, J. (2000). Aspirin. Circulation, 101, 1206-1218.
3. BURGER, C., HAO, J., YING, Q., ISOBE, H., SAWAMURA, M., NAKAMURA, E. & CHU, B. (2004). Multilayer vesicles and vesicle clusters formed by the fullerene-based surfactant C60(CH3)5K. J. Colloid Interface Sci., 275, 632-641.
4. BUXTON, D.B., LEE, S.C., WICKLINE, S.A., FERRARI, M. & FOR THE WORKING GROUP MEMBERS (2003). Recommendations of the National Heart, Lung, and Blood Institute Nanotechnology Working Group. Circulation, 108, 2737-2742.
5. CHELLAT, F., GRANDJEAN-LAQUERRIERE, A., NAOUR, R.L., FERNANDES, J., YAHIA, L.H., GUENOUNOU, M. & LAURENT-MAQUIN, D. (2005). Metalloproteinase and cytokine production by THP-1 macrophages following exposure to chitosan-DNA nanoparticles. Biomaterials, 26, 961-970.
6. CHUNG, A.W., JURASZ, P., HOLLENBERG, M.D. & RADOMSKI, M.W. (2002). Mechanisms of action of proteinase-activated receptor agonists on human platelets. Br. J. Pharmacol., 135, 1123-1132.
7. COLLER, B.S. (1995). Blockade of platelet GPIIb/IIIa receptors as an antithrombotic strategy. Circulation, 92, 2373-2380.
8. DAI, H. (2002). Carbon nanotubes: synthesis, integration, and properties. Accounts Chem. Res., 35, 1035-1044.
9. DIOCIAIUTI, M., BALDUZZI, M., DE BERARDIS, B., CATTANI, G., STACCHINI, G., ZIEMACKI, G., MARCONI, A. & PAOLETTI, L. (2001). The Two PM2.5 (Fine) and PM2.5-10 (Coarse) fractions: evidence of different biological activity. Environm. Res., 86, 254-262.
10. DONALDSON, K., STONE, V., SEATON, A. & MACNEE, W. (2001). Ambient particle inhalation and the cardiovascular system: potential mechanisms. Environm. Health Perspect., 109 (Suppl. 4), 523-527.
11. FERNANDEZ-PATRON, C., MARTINEZ-CUESTA, M.A., SALAS, E., SAWICKI, G., WOZNIAK, M., RADOMSKI, M.W. & DAVIDGE, S.T. (1999). Differential regulation of platelet aggregation by matrix metalloproteinases-9 and -2. Thromb. Haemostasis, 82, 1730-1735.
12. JURASZ, P., ALONSO, D., CASTRO-BLANCO, S., MURAD, F. & RADOMSKI, M.W. (2003). Generation and role of angiostatin in human platelets. Blood, 102, 3217-3223.
13. JURASZ, P., CHUNG, A.W., RADOMSKI, A. & RADOMSKI, M.W. (2002). Nonremodeling properties of matrix metalloproteinases: the platelet connection. Circulat. Res. (online), 90, 1041-1043.
14. JURASZ, P., RADOMSKI, A., SAWICKI, G., MAYERS, I. & RADOMSKI, M.W. (2000). Nitric oxide and platelet function. In: Nitric oxide Biol. Pathobiol., ed. Ignarro, L.J., pp. 823-840. San Diego, San Francisco, New York, Boston, Sydney, Tokyo: Academic Press.
15. JURASZ, P., STEWART, M.W., RADOMSKI, A., KHADOUR, F., DUSZYK, M. & RADOMSKI, M.W. (2001). Role of von Willebrand factor in tumour cell-induced platelet aggregation: differential regulation by NO and prostacyclin. Br. J. Pharmacol., 134, 1104-1112.
16. KAUF, A.C.W., HOUGH, S.M. & BOWDITCH, R.D. (2001). Recognition of fibronectin by the platelet integrin IIb3 involves an extended interface with multiple electrostatic interactions. Biochemistry, 40, 915-9166.
17. KOLODGIE, F.D., JOHN, M., KHURANA, C., FARB, A., WILSON, P.S., ACAMPADO, E., DESAI, N., SOON-SHIONG, P. & VIRMANI, R. (2002). Sustained reduction of in-stent neointimal growth with the use of a novel systemic nanoparticle paclitaxel. Circulation, 106, 1195-1198.
18. KURZ, K.D., MAIN, B.W. & SANDUSKY, G.E. (1990). Rat model of arterial thrombosis induced by ferric chloride. Thromb. Res., 60, 269-280.
19. LAVAN, D.A., LYNN, D.M. & LANGER, R. (2002). Moving smaller in drug discovery and delivery. Nat. Rev. Drug Discov., 1, 77-84.
20. LAVAN, D.A., MCGUIRE, T. & LANGER, R. (2003). Small-scale systems for in vivo drug delivery. Nat. Biotechnol., 21, 1184-1191.
21. LÉVY-TOLEDANO, S. (1999). Platelet signal transduction pathways: could we organize them into a 'hierarchy'? Pathophysiol. Haemostasis Thromb., 29, 4-15.
22. MARTIN, C.R. & KOHLI, P. (2003). The emerging field of nanotube biotechnology. Nat. Rev. Drug Discov., 2, 29-37.
23. MARTINEZ-CUESTA, M.A., SALAS, E., RADOMSKI, A. & RADOMSKI, M.W. (2001). Matrix metalloproteinase-2 in platelet adhesion to fibrinogen: interactions with nitric oxide. Med. Sci. Monit., 7, 646-651.
24. MOGHIMI, S.M., HUNTER, A.C. & MURRAY, J.C. (2005). Nanomedicine: current status and future prospects. FASEB J., 19, 311-330.
25. MOORE, V.C., STRANO, M.S., HAROZ, E.H., HAUGE, R.H. & SMALLEY, R.E. (2003). Individually suspended single-walled carbon nanotubes in various surfactants. Nanoletters, 3, 1379-1382.
26. MURUGAPPAN, S., TULUC, F., DORSAM, R.T., SHANKAR, H. & KUNAPULI, S.P. (2004). Differential role of protein kinase C{delta} isoform in agonist-induced dense granule secretion in human platelets. J. Biol. Chem., 279, 2360-2367.
27. NEEDLEMAN, P., MONCADA, S., BUNTING, S., VANE, J.R., HAMBERG, M. & SAMUELSSON, B. (1976). Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides. Nature, 261, 558-560.
28. NEMMAR, A., HOET, P.H.M., DINSDALE, D., VERMYLEN, J., HOYLAERTS, M.F. & NEMERY, B. (2003). Diesel exhaust particles in lung acutely enhance experimental peripheral thrombosis. Circulation, 107, 1202-1208.
29. NEMMAR, A., HOET, P.H.M., VANQUICKENBORNE, B., DINSDALE, D., THOMEER, M., HOYLAERTS, M.F., VANBILLOEN, H., MORTELMANS, L. & NEMERY, B. (2002). Passage of inhaled particles into the blood circulation in humans. Circulation, 105, 411-414.
30. OBERDORSTER, E. (2004). Manufactured nanomaterials (fullerenes, C60) induce oxidative stress in the brain of juvenile largemouth bass. Environm. Health Perspect., 112, 1058-1062.
31. O'CONNELL, M.J., BACHILO, S.M., HUFFMAN, C.B., MOORE, V.C., STRAND, M.S., HAROZ, E.H., RIALON, K.L., BOUL, P.J., NOON, W.H., KITTRELL, C., MA, J., HAUGE, R.H., WEISMAN, R.B. & SMALLEY, R.E. (2002). Band gap fluorescence from individual single-walled carbon nanotubes. Science, 297, 593-596.
32. PETERS, A., DOCKERY, D.W., MULLER, J.E. & MITTLEMAN, M.A. (2001). Increased particulate air pollution and the triggering of myocardial infarction. Circulation, 103, 2810-2815.
33. RADOMSKI, A., JURASZ, P., SANDERS, E.J., OVERALL, CM., BIGG, H.F., EDWARDS, D.R. & RADOMSKI, M.W. (2002). Identification, regulation and role of tissue inhibitor of metalloproteinases-4 (TIMP-4) in human platelets. Br. J. Pharmacol., 137, 1330-1338.
34. RADOMSKI, A., STEWART, M.W., JURASZ, P. & RADOMSKI, M.W. (2001). Pharmacological characteristics of solid-phase von Willebrand factor in human platelets. Br. J. Pharmacol., 134, 1013-1020.
35. RADOMSKI, M. & MONCADA, S. (1983). An improved method for washing of human platelets with prostacyclin. Thromb. Res., 30, 383-389.
36. RADOMSKI, M.W. & RADOMSKI, A.S. (2000). Regulation of blood cell function by the endothelial cells. In: Vascular Endothelium in Human Physiology and Pathophysiology, eds. Vallance, P. & Webb, D. pp. 95-106. London: Harwood Academic Publishers.
37. RADOMSKI, M.W., REES, D.D., DUTRA, A. & MONCADA, S. (1992). S-nitroso-glutathione inhibits platelet activation in vitro and in vivo. Br. J. Pharmacol., 107, 745-749.
38. RICHARD, C., BALAVOINE, F., SCHULTZ, P., EBBESEN, T.W. & MIOSKOWSKI, C. (2003). Supramolecular self-assembly of lipid derivatives on carbon nanotubes. Science, 300, 775-778.
39. RUSTOM, A., SAFFRICH, R., MARKOVIC, I., WALTHER, P. & GERDES, H.-H. (2004). Nanotubular highways for intercellular organelle transport. Science, 303, 1007-1010.
40. SAWICKI, G., SALAS. E., MURAT, J., MISZTA-LANE, H. & RADOMSKI, M.W. (1997). Release of gelatinase A during platelet activation mediates aggregation. Nature, 386, 616-619.
41. SAWICKI, G., SANDERS, E.J., SALAS, E., WOZNIAK, M., RODRIGO, J. & RADOMSKI, M.W. (1998). Localization and translocation of MMP-2 during aggregation of human platelets. Thromb. Haemostasis, 80, 836-839.
42. SEATON, A., SOUTAR, A., CRAWFORD, V., ELTON, R., MCNERLAN, S., CHERRIE, J., WATT, M., AGIUS, R. & STOUT, R. (1999). Particulate air pollution and the blood. Thorax, 54, 1027-1032.
43. SHEU, J.R., FONG, T.H., LIU, C.M., SHEN, M.Y., CHEN, T.L., CHANG, Y., LU, M.S. & HSIAO, G. (2004). Expression of matrix metalloproteinase-9 in human platelets: regulation of platelet activation in in vitro and in vivo studies. Br. J. Pharmacol., 143, 193-201.
44. SORENSEN, M., DANESHVAR, B., HANSEN, M., DRAGSTED, L.O., HERTEL, O., KNUDSEN, L. & LOFT, S. (2003). Personal PM2.5 exposure and markers of oxidative stress in blood. Environm. Health Perspect., 111, 161-166.
45. STAMLER, J., JARAKI, O., OSBORNE, J., SIMON, D., KEANEY, J., VITA, J., SINGEL, D., VALERI, C. & LOSCALZO, J. (1992). Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc. Natl. Acad. Sci. U.S.A., 89, 7674-7677.
46. STUART, C. (2003). Survey finds the smaller in size, the bigger the possible risks. URL: http://www.smalltimes.com/document_display.cfm?document_id= 5861.
47. SUWA, T., HOGG, J.C., QUINLAN, K.B., OHGAMI, A., VINCENT, R. & VAN EEDEN, S.F. (2002). Particulate air pollution induces progression of atherosclerosis. J. Am. College Cardiol., 39, 935-942.
48. THE ROYAL SOCIETY AND ROYAL ACADEMY OF ENGINEERING (2004). Nanoscience and nanoteclmology: opportunities and uncertainties, http://www.nanotec.org.uk/ finalReport.htm.
49. VANE, J.R., BAKHLE, Y.S. & BOTTING, R.M. (1998). Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol. Toxicol., 38, 97-120.
50. WANG, X. & XU, L. (2005). An optimized murine model of ferric chloride-induced arterial thrombosis for thrombosis research. Thromb. Res., 115, 95-100.
51. WESTEDT, U., BARBU-TUDORAN, L., SCHAPER, A.K., KALINOWSKI, M., ALFKE, H. & KISSEL, T. (2004). Effects of different application parameters on penetration characteristics and arterial vessel wall integrity after local nanoparticle delivery using a porous balloon catheter. Eur. J. Pharm. Biopharm., 58, 161-168.
52. WHITE, J.G. & ESCOLAR, G. (2000). EDTA-induced changes in platelet structure and function: adhesion and spreading. Platelets, 11, 56-61.
53. WINTER, P.M., MORAWSKI, A.M., CARUTHERS, S.D., FUHRHOP, R.W., ZHANG, H., WILLIAMS, T.A., ALLEN, J.S., LACY, E.K., ROBERTSON, J.D., LANZA, G.M. & WICKLINE, S.A. (2003). Molecular imaging of angiogenesis in early-stage atherosclerosis with {alpha}v{beta}3-integrin-targeted nanoparticles. Circulation, 108, 2270-2274.